Perry Baromedical Corporation Offers Hospitals State-of the-Art Hyperbaric Oxygen Chambers
With over 7,000,000 Americans suffering from chronic wounds and 60,000 Americans dying annually from wound complications, the need for more aggressive wound treatment options is substantial. The discovery that hyperbaric oxygen can hasten and even help difficult cases of non-healing wounds to improve is a major advancement and one of the more important medical breakthroughs of our time.
Riviera Beach, FL (PRWEB) November 28, 2007
Hospital-based wound care accounts for approximately $7.5 billion dollars in medical costs annually, and the number is steadily increasing. As the Boomer generation ages and with diabetes, heart disease, and obesity on the rise, the wound care market is growing at a significant rate. Although Hyperbaric Oxygen Therapy (HBOT) has been utilized for over forty years, HBOT wound care programs are now helping to revolutionize how hospitals deal with society's shifting health care challenges.
Perry Baromedical, a leader in hyperbaric oxygen chambers, is on the cutting edge of HBOT with their SIGMA 40, the largest monoplace chamber in the industry. The larger size allows for added comfort while promoting increased patient compliance. Over five million hours of hyperbaric treatments have been safely performed in Perry chambers. They are the only company to design, manufacture, install and service monoplace, dualplace and multiplace hyperbaric chambers. In 1981, Perry Baromedical Corporation installed their first chamber, and since that time they have installed hundreds more both nationally and internationally.
With Addition of Wound Care Clinics, Hospitals' Revenue Expected to Exceed $13 Billion Annually
Hospitals with wound care programs that utilize Hyperbaric Oxygen Therapy can anticipate a gain in additional yearly revenue of an estimated 25%-40% and will typically see profits in the first year. Based on current growth trends, by the year 2010 wound care clinics that offer HBOT will exceed $13 billion dollars annually.
Hyperbaric Oxygen Therapy (HBOT) is used primarily for the treatment of non-healing wounds. The Centers for Medicaid and Medicare Services recognize a total of 15 approved conditions. In America alone, 21 million people suffer from diabetes; 60 million adults are clinically obese; and 35 million people are over the age of 65. As these numbers continue to rise, so does the need for aggressive wound treatment options. Currently, only 30% of hospitals in half the states have an outpatient wound care program that utilizes HBOT. Hospitals without HBOT have a significant opportunity to meet the needs of this growing market and earn substantial profits.
Contact: Fleur Henry at Anthony Mora Communications, Inc.
909-908-3788 or 323.874.2933
# # #
